ARCHIVES

High Dose Chemotherapy Significantly Prolongs Survival In ECOG Clinical Trial

This article is from The Cancer Letter archive.

Vol. 31 No. 11 | November 28, 2008

Download PDF Visit The Full Archive

Related Articles

DCT Board Approves Recompetition Of Drug Development Contracts

June 25, 1993

Breast Cancers Detected By Mammograms Have Better Prognosis, Trials Analysis Finds

September 30, 2005

In Brief: NCI Holding Up Regional Cooperative Group RFA Until Department Approves New Mechanism

February 27, 1981

Group Chairs Respond to Center Directors’ White Paper

April 1, 2011

DeVita Accepts “Chop Lie” Cancer Control Elements In CCOP; RFA Delays Until After May NCAB Meeting

March 12, 1982

2015 Goal Not a Dream, But a Vision, Director Says

July 18, 2003